DRD1 and drug-induced dyskinesia: In addition, dopamine precursor molecule 3,4-dihydroxyphenyl-l-alanine (l-DOPA)-induced dyskinesias and up-regulation of DeltaFosB can be blocked by genetic inactivation of DRD1 (Darmopil et al, 2009).